The lessened cumulative incidences of day 100 (12% versus 18%, P =1.4) and 1-year (20% versus 32%, P =1.4) NRM among nonmyeloablative patients did not reach statistical significance.
← all excerpts
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation.
1
—
—